Risk assessment and drug interruption guidelines for dentoalveolar surgery in patients with osteoporosis receiving anti-resorptive therapy

Medication-related osteonecrosis of the jaw (MRONJ) is a rare and challenging complication of anti-resorptive therapy. This review addresses the critical issue of risk management in patients with osteoporosis who require dentoalveolar surgery while undergoing anti-resorptive therapy. Dental practiti...

Full description

Bibliographic Details
Published in:	Journal of Dental Sciences
Main Authors:	Ling-Ying Wei, Ching-Ming Chiu, Sang-Heng Kok, Hao-Hong Chang, Shih-Jung Cheng, Hung-Ying Lin, Wei-Yih Chiu, Jang-Jaer Lee
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Subjects:	Anti-resorptive agents Dentoalveolar surgery Drug discontinuation Medication-related osteonecrosis of the jaw (MRONJ) Risk assessment
Online Access:	http://www.sciencedirect.com/science/article/pii/S1991790225000340

Similar Items

Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series
by: Filipa Frutuoso, et al.
Published: (2024-09-01)

Implications in dental treatment during the use of antiresorptive drugs - a literature review
by: Aleksandra Dziewulska, et al.
Published: (2024-10-01)

Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy
by: Dávid Száraz, et al.
Published: (2024-12-01)

Clinical and Histological Evaluation of Jaw Osteonecrosis Unrelated to Anti-Bone Resorption Drugs
by: Cinzia Casu, et al.
Published: (2025-04-01)

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats
by: Suzanna L. Hatunen, et al.
Published: (2024-08-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

MRONJ and VIT D insufficiency
by: Gholamreza Shirani, et al.
Published: (2021-07-01)

Medication‐related osteonecrosis of the jaw and successful implant treatment in a patient on high‐dose antiresorptive medication: A case report
by: Camilla Ottesen, et al.
Published: (2022-10-01)

Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy
by: Derek Oryniak, et al.
Published: (2024-07-01)

Photobiomodulation in Medication-Related Osteonecrosis of the Jaw: Outcomes in Stage I and Its Adjunctive Role in Advanced Cases
by: Filip Michalak, et al.
Published: (2025-04-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

The combined use of photobiomodulation therapy and platelet-rich fibrin for the management of two MRONJ stage II cases: An alternative approach
by: Konstantinos Valamvanos, et al.
Published: (2022-12-01)

Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis
by: Suad Aljohani
Published: (2023-09-01)

Awareness and practice of dentists in gulf cooperation council countries regarding medication-related osteonecrosis of the jaw – A web-based survey
by: Mohammad Zakaria Nassani, et al.
Published: (2023-10-01)

The Role of the Laser Photobiomodulation (PBM) in the Management of Patients at Risk or Affected by MRONJ
by: Alessandro Del Vecchio, et al.
Published: (2022-01-01)

Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
by: Francesco Erovigni, et al.
Published: (2016-10-01)

Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort
by: Cristina Mirelli, et al.
Published: (2022-05-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw
by: Salvatore D’Amato, et al.
Published: (2021-09-01)

A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials
by: Reem Hanna, et al.
Published: (2024-07-01)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
by: Aya Alsalih, et al.
Published: (2021-07-01)

Influences of Compressive Force and Zoledronic Acid on Osteoblast Proliferation and Differentiation: An In Vitro Study
by: Kazuyuki Yusa, et al.
Published: (2021-11-01)

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01)

The Bisphosphonate Accumulation Index (BAI): A Quantitative Metric for Cumulative Antiresorptive Exposure in Pre-Procedural Dental and Surgical Assessment
by: Piero Antonio Zecca, et al.
Published: (2026-06-01)

Geranylgeraniol (GGOH), incorporated into a bone cement pellet promotes osteoclast function and healing in a model of medication-related osteonecrosis of the jaw
by: George Feldman, et al.
Published: (2024-03-01)

Bisphosphonates: An update to the general dentist
by: Varun Dahiya, et al.
Published: (2013-01-01)

The Role of Cone Beam Computed Tomography (CBCT) in the Diagnosis and Clinical Management of Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Yui Yin Ko, et al.
Published: (2024-08-01)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
by: Abdulrhman Al Abdullateef, et al.
Published: (2020-06-01)

From Pain to Recovery: The Impact of Laser-Assisted Therapy in Dentistry and Cranio-Facial Medicine
by: Andreea Kui, et al.
Published: (2025-03-01)

Geranylgeraniol Application in Human Osteoblasts and Osteoclasts for Reversal of the Effect of Bisphosphonates
by: Junho Jung, et al.
Published: (2023-06-01)

MicroRNA in medication related osteonecrosis of the jaw: a review
by: Siti Salmiah Mohd Yunus, et al.
Published: (2023-04-01)

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
by: Winnie Zee Man Wat
Published: (2016-10-01)

Oral health status and quality of life in female patients receiving low dose bone-modifying agents for cancer treatment-induced bone loss: a single-center exploratory study
by: Rodolfo Mauceri, et al.
Published: (2025-10-01)

Bone resection methods in medication-related osteonecrosis of the jaw in the mandible: An investigation of 206 patients undergoing surgical treatment
by: Koki Suyama, et al.
Published: (2024-07-01)

Bone scintigraphy and positron emission tomography in the early diagnosis of MRONJ
by: Pergolini Daniele, et al.
Published: (2025-02-01)

Oral Squamous Cell Carcinoma Mimicking Medication-Related Osteonecrosis of the Jaws (MRONJ): A Case Series
by: Rodolfo Mauceri, et al.
Published: (2021-11-01)

Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw
by: Jeong Won Shin, et al.
Published: (2024-04-01)

Osimertinib: Another medication related to osteonecrosis of the jaws? A case report and literature review
by: Feng Wang, et al.
Published: (2022-08-01)

Placement of Dental Implants in Patients Receiving Bisphosphonate Therapy
by: Levente Palásti, et al.
Published: (2019-10-01)

Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP)
by: L. Landi, et al.
Published: (2023-07-01)